{name}
{subtitle}
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
city
~10 mi. (West Des Moines, Iowa, +523 more cities)
facility
Mercy Medical Center-West Lakes
drug
cabozantinib, +2 more drugs
drug type
immunotherapy, +1 more type
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
city
~10 mi. (West Des Moines, Iowa, +454 more cities)
facility
Mercy Medical Center-West Lakes
drug
brentuximab vedotin, +7 more drugs
drug type
chemotherapy, +3 more types
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~10 mi. (West Des Moines, Iowa, +825 more cities)
facility
Mercy Medical Center-West Lakes, +1 more facility
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
city
~10 mi. (West Des Moines, Iowa, +327 more cities)
facility
Methodist West Hospital, +1 more facility
drug
bortezomib, +3 more drugs
drug type
chemotherapy, +3 more types
S0820, Adenoma and Second Primary Prevention Trial
city
~10 mi. (West Des Moines, Iowa, +616 more cities)
facility
Methodist West Hospital, +1 more facility
condition
Colon Carcinoma, +1 more condition
drug
eflornithine, +2 more drugs
drug type
chemotherapy, +1 more type